127 related articles for article (PubMed ID: 2354227)
1. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.
Keks NA; Copolov DL; Kulkarni J; Mackie B; Singh BS; McGorry P; Rubin RT; Hassett A; McLaughlin M; van Riel R
Biol Psychiatry; 1990 Jun; 27(11):1203-15. PubMed ID: 2354227
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone response to clonidine in neuroleptic-free patients with multidagnostically defined schizophrenia.
Keks NA; Copolov DL; McKenzie DP; Kulkarni J; Hassett A; Matheson B; Hill C; Mackie B; Singh B; Hirt J
Psychiatry Res; 1993 Jul; 48(1):79-90. PubMed ID: 8416019
[TBL] [Abstract][Full Text] [Related]
3. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
Kulkarni J; Keks NA; Stuart G; Mackie B; Minas IH; Singh BS; Copolov DL
Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
[TBL] [Abstract][Full Text] [Related]
4. Multidiagnostic evaluation of prolactin response to haloperidol challenge in schizophrenia: maximal blunting in Kraepelinian patients.
Keks NA; McKenzie DP; Low LH; McGorry PD; Hill C; Kulkarni J; Singh BS; Copolov DL
Biol Psychiatry; 1992 Sep; 32(5):426-37. PubMed ID: 1486148
[TBL] [Abstract][Full Text] [Related]
5. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.
Newcomer JW; Riney SJ; Vinogradov S; Csernansky JG
Psychiatry Res; 1992 Mar; 41(3):191-202. PubMed ID: 1594706
[TBL] [Abstract][Full Text] [Related]
6. Basal and haloperidol-stimulated prolactin and symptoms of nonaffective and affective psychoses in neuroleptic-free men.
Keks NA; Copolov DL; McKenzie DP; Kulkarni J; Hill C; Hope JD; Singh BS
Biol Psychiatry; 1995 Feb; 37(4):229-34. PubMed ID: 7711159
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U
Acta Psychiatr Belg; 1983; 83(1):57-68. PubMed ID: 6613612
[TBL] [Abstract][Full Text] [Related]
8. Plasma prolactin response to domperidone in acute schizophrenia and schizophreniform illness.
Nerozzi D; Magnani A; Sforza V; Scaramucci E; Cerilli M; Moretti C; Frajese G; Antonozzi I; Meltzer HY
Psychiatry Res; 1990 Nov; 34(2):139-47. PubMed ID: 2149613
[TBL] [Abstract][Full Text] [Related]
9. Prolactin response to low-dose haloperidol challenge in schizophrenic, non-schizophrenic psychotic, and control subjects.
Copolov DL; Keks NA; Kulkarni J; Singh BS; McKenzie D; McGorry P; Hill C
Psychoneuroendocrinology; 1990; 15(3):225-31. PubMed ID: 2255750
[TBL] [Abstract][Full Text] [Related]
10. Prolactin responses to haloperidol in drug-free and treated schizophrenic patients.
Markianos M; Sakellariou G; Bistolaki E
J Neural Transm Gen Sect; 1991; 83(1-2):37-42. PubMed ID: 2018629
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine therapy in chronic schizophrenia: effects on symptomatology, sleep patterns, and prolactin response to stimulation.
Brambilla F; Scarone S; Pugnetti L; Massironi R; Penati G; Nobile P
Psychiatry Res; 1983 Mar; 8(3):159-69. PubMed ID: 6574535
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
Markianos M; Hatzimanolis J; Lykouras L
Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
[TBL] [Abstract][Full Text] [Related]
13. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
[TBL] [Abstract][Full Text] [Related]
14. Suspension therapy in acute schizophrenia. Clinical and neuroendocrine/biochemical effects of abrupt discontinuation of neuroleptic medication.
Kuhs H; Folkerts H
Neuropsychobiology; 1995; 31(3):135-45. PubMed ID: 7609862
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
[TBL] [Abstract][Full Text] [Related]
16. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
[TBL] [Abstract][Full Text] [Related]
17. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
[TBL] [Abstract][Full Text] [Related]
18. Serum prolactin as a correlate of clinical response to haloperidol.
Van Putten T; Marder SR; Mintz J
J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154
[TBL] [Abstract][Full Text] [Related]
19. Prolactin response to thyrotropin-releasing hormone in schizoaffective depressed compared to depressed and schizophrenic men and healthy controls.
Wahby VS; Ibrahim GA; LeeChuy I; Saddik FW; Giller EL; Mason JW
Schizophr Res; 1990; 3(5-6):277-81. PubMed ID: 2126454
[TBL] [Abstract][Full Text] [Related]
20. Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder.
Chou JC; Douyon R; Czobor P; Volavka J; Cooper TB
Psychiatry Res; 1998 Oct; 81(1):51-5. PubMed ID: 9829650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]